🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

5 analyst picks: ConocoPhillips upgraded following OPEC+ announcement | Pro Recap

Published 05/04/2023, 07:04 pm
© Reuters.
ZION
-
COP
-
UNH
-
OKE
-
AVAV
-

By Davit Kirakosyan

Investing.com -- Here is your daily Pro Recap of the biggest analyst picks you may have missed since yesterday.

ConocoPhillips upgraded to Hold following OPEC+ announcement of output cuts

Societe Generale upgraded ConocoPhillips (NYSE:COP) to Hold from Sell while cutting its price target to $105.00 from $114.00. Shares are up more than 1% pre-market today.

Shares jumped 9% on Monday after Saudi Arabia and other OPEC+ oil producers announced further oil output cuts of around 1.16 million barrels per day.

As always, InvestingPro subscribers got this news first. Start your free 7-day trial to get on board.

AeroVironment shares jump on Raymond James upgrade

AeroVironment (NASDAQ:AVAV) shares surged more than 10% yesterday after Raymond James upgraded the company to Strong Buy from Outperform and raised its price target to $130.00 from $105.00.

According to the firm, consensus models have miscalculated across 3-vectors, resulting in a considerable deviation between actual outcomes and projections. Specifically, these models have (1) not fully recognized the recent momentum in orders, (2) underestimated the speed at which orders will translate into revenue, and (3) overestimated the adverse effects of supply chain limitations on product delivery.

The firm increased its Street high 2024 estimate by approximately $100 million to $705M in sales or around 21% above the Street and noted that this could still prove conservative.

ONEOK upgraded to Buy, well positioned to achieve the high end of its 2023 guidance

Citi upgraded ONEOK (NYSE:OKE) to Buy from Neutral and raised its price target to $72.00 from $71.00, driven by two key factors. Firstly, the company is well-positioned to achieve the high end of its 2023 guidance range. Secondly, Citi expressed skepticism that the Street consensus accurately reflects the company's torque to volume growth.

The company will report its Q1/23 earnings results on May 2. Wall Street analysts expect an EPS of $1.96 and revenue of $5.52B.

2 more upgrades

Raymond James upgraded UnitedHealth Group (NYSE:UNH) to Strong Buy from Outperform and raised its price target to $630.00 from $615.00. The company is set to release its Q1/23 earnings on April 14.

Baird upgraded Zions Bancorporation (NASDAQ:ZION) to Outperform from Neutral with a price target of $60.00 ahead of the upcoming Q1/23 earnings announcement, scheduled on April 19.

Shares are up more than 2% pre-market today.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.